Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 14:13:49 UTC |
---|
Update Date | 2021-09-26 23:09:02 UTC |
---|
HMDB ID | HMDB0254782 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Adavosertib |
---|
Description | MK-1775 belongs to the class of organic compounds known as phenylpiperazines. Phenylpiperazines are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group. MK-1775 is a very strong basic compound (based on its pKa). University of Michigan researchers are as of 2019 planning a phase 2 study. It is being investigated as a treatment for pancreatic cancer with phase 1 trial. Adavosertib (development codes AZD1775, MK-1775) is an experimental anti-cancer drug candidate. It is a small molecule inhibitor of the tyrosine kinase WEE1 with potential antineoplastic sensitizing activity. It is being developed by AstraZeneca. This compound has been identified in human blood as reported by (PMID: 31557052 ). Adavosertib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Adavosertib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CN1CCN(CC1)C1=CC=C(NC2=NC=C3C(=O)N(CC=C)N(C3=N2)C2=NC(=CC=C2)C(C)(C)O)C=C1 InChI=1S/C27H32N8O2/c1-5-13-34-25(36)21-18-28-26(29-19-9-11-20(12-10-19)33-16-14-32(4)15-17-33)31-24(21)35(34)23-8-6-7-22(30-23)27(2,3)37/h5-12,18,37H,1,13-17H2,2-4H3,(H,28,29,31) |
---|
Synonyms | Value | Source |
---|
2-Allyl-1-(6-(2-hydroxy-2-propanyl)-2-pyridinyl)-6-((4-(4-methyl-1-piperazinyl)phenyl)amino)-1,2-dihydro-3H-pyrazolo(3,4-D)pyrimidin-3-one | MeSH |
|
---|
Chemical Formula | C27H32N8O2 |
---|
Average Molecular Weight | 500.607 |
---|
Monoisotopic Molecular Weight | 500.264822302 |
---|
IUPAC Name | 1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-(prop-2-en-1-yl)-1H,2H,3H-pyrazolo[3,4-d]pyrimidin-3-one |
---|
Traditional Name | 1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-(prop-2-en-1-yl)pyrazolo[3,4-d]pyrimidin-3-one |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN1CCN(CC1)C1=CC=C(NC2=NC=C3C(=O)N(CC=C)N(C3=N2)C2=NC(=CC=C2)C(C)(C)O)C=C1 |
---|
InChI Identifier | InChI=1S/C27H32N8O2/c1-5-13-34-25(36)21-18-28-26(29-19-9-11-20(12-10-19)33-16-14-32(4)15-17-33)31-24(21)35(34)23-8-6-7-22(30-23)27(2,3)37/h5-12,18,37H,1,13-17H2,2-4H3,(H,28,29,31) |
---|
InChI Key | BKWJAKQVGHWELA-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylpiperazines. Phenylpiperazines are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazinanes |
---|
Sub Class | Piperazines |
---|
Direct Parent | Phenylpiperazines |
---|
Alternative Parents | |
---|
Substituents | - Phenylpiperazine
- N-arylpiperazine
- 2-pyrazolylpyridine
- Pyrazolopyrimidine
- Pyrazolo[3,4-d]pyrimidine
- Tertiary aliphatic/aromatic amine
- Dialkylarylamine
- Aniline or substituted anilines
- Aminopyrimidine
- N-alkylpiperazine
- N-methylpiperazine
- Benzenoid
- Pyrazolinone
- Pyridine
- Monocyclic benzene moiety
- Pyrimidine
- Heteroaromatic compound
- Vinylogous amide
- Azole
- Pyrazole
- Tertiary alcohol
- Tertiary aliphatic amine
- Lactam
- Tertiary amine
- Azacycle
- Secondary amine
- Hydrocarbon derivative
- Organic oxygen compound
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Alcohol
- Aromatic alcohol
- Organic oxide
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Adavosertib,2TMS,isomer #1 | C=CCN1C(=O)C2=CN=C(N(C3=CC=C(N4CCN(C)CC4)C=C3)[Si](C)(C)C)N=C2N1C1=CC=CC(C(C)(C)O[Si](C)(C)C)=N1 | 4320.3 | Semi standard non polar | 33892256 | Adavosertib,2TMS,isomer #1 | C=CCN1C(=O)C2=CN=C(N(C3=CC=C(N4CCN(C)CC4)C=C3)[Si](C)(C)C)N=C2N1C1=CC=CC(C(C)(C)O[Si](C)(C)C)=N1 | 3841.5 | Standard non polar | 33892256 | Adavosertib,2TMS,isomer #1 | C=CCN1C(=O)C2=CN=C(N(C3=CC=C(N4CCN(C)CC4)C=C3)[Si](C)(C)C)N=C2N1C1=CC=CC(C(C)(C)O[Si](C)(C)C)=N1 | 5333.7 | Standard polar | 33892256 | Adavosertib,2TBDMS,isomer #1 | C=CCN1C(=O)C2=CN=C(N(C3=CC=C(N4CCN(C)CC4)C=C3)[Si](C)(C)C(C)(C)C)N=C2N1C1=CC=CC(C(C)(C)O[Si](C)(C)C(C)(C)C)=N1 | 4668.3 | Semi standard non polar | 33892256 | Adavosertib,2TBDMS,isomer #1 | C=CCN1C(=O)C2=CN=C(N(C3=CC=C(N4CCN(C)CC4)C=C3)[Si](C)(C)C(C)(C)C)N=C2N1C1=CC=CC(C(C)(C)O[Si](C)(C)C(C)(C)C)=N1 | 4187.1 | Standard non polar | 33892256 | Adavosertib,2TBDMS,isomer #1 | C=CCN1C(=O)C2=CN=C(N(C3=CC=C(N4CCN(C)CC4)C=C3)[Si](C)(C)C(C)(C)C)N=C2N1C1=CC=CC(C(C)(C)O[Si](C)(C)C(C)(C)C)=N1 | 5327.5 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Adavosertib GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Adavosertib GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Adavosertib GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Adavosertib GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adavosertib 10V, Positive-QTOF | splash10-0ue9-0001940000-5b83b5864f697d750529 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adavosertib 20V, Positive-QTOF | splash10-0006-8102910000-39a8bbc2d913e0e4d173 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adavosertib 40V, Positive-QTOF | splash10-0006-8425900000-eae66f73c2cdd34b9e78 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adavosertib 10V, Negative-QTOF | splash10-0002-0000900000-2f1d9d66387e2fc60ab4 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adavosertib 20V, Negative-QTOF | splash10-0aos-0021900000-9aa18f6037de276afc64 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adavosertib 40V, Negative-QTOF | splash10-0296-7674900000-5e7e793c9f9eb5c15f13 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adavosertib 10V, Negative-QTOF | splash10-0005-0000900000-f153b55df66bfd40cbdc | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adavosertib 20V, Negative-QTOF | splash10-0a4i-0000900000-615648cb2d70b0db1813 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adavosertib 40V, Negative-QTOF | splash10-0159-0331900000-7e18c43e0aa7d96a2050 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adavosertib 10V, Positive-QTOF | splash10-0f89-0000980000-87ddff9e3dbe8821a753 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adavosertib 20V, Positive-QTOF | splash10-0k96-0000930000-d9bd413acb9b9b4a4d20 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adavosertib 40V, Positive-QTOF | splash10-03dl-0000900000-a0500025763cdd5d7ba0 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|